Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F5QRC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,259
Award facts
- Contract value 100% obligated
- $30,258.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,258.98 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a PCSK9 inhibitor injectable medication used to treat high cholesterol. This firm fixed-price, non-set-aside contract was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply vehicle valued through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for the Defense Health Agency and other military healthcare systems. The company's extensive contract history with DLA demonstrates its capability to fulfill competitive procurement requirements across diverse therapeutic domains, ranging from specialty medications to vaccines and medical devices. This delivery order represents a routine replenishment transaction under the prime indefinite delivery vehicle, supporting ongoing pharmaceutical supply needs for federal defense health operations.
Quick answers
Who was awarded contract SPE2DR26F5QRC?
SPE2DR26F5QRC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F5QRC worth?
The government has obligated $30,259 on SPE2DR26F5QRC.
Is contract SPE2DR26F5QRC an order under another contract?
Yes. SPE2DR26F5QRC is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QRC competed?
The extent of competition for SPE2DR26F5QRC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award